Everett Neville serves as executive vice president, strategy, corporate development and solutions, responsible for mapping Cigna Corporation’s long-term growth through his leadership of the company’s strategy, corporate and business development, Cigna Ventures and Cigna Solutions. He brings together enterprise strategy and solutions to accelerate cross-business value creation through Cigna and Evernorth.
Previously, Neville served as senior vice president, value creation, where he leveraged his more than 20 years of experience with Express Scripts to ensure the company – as well as our customers and clients – realize the benefits expected from the Cigna / Express Scripts® combination and from Evernorth SM, Cigna’s health services organization.
Prior to the combination, he was executive vice president, strategy, supply chain and specialty pharmacy, and chief value officer of Express Scripts. Under his dynamic leadership, Express Scripts brought to market industry-leading solutions and strategies that delivered value to Express Scripts clients, members and shareholders, and helped to shape the rapidly evolving specialty pharmacy landscape.
Neville joined Express Scripts in 1998. He has held diverse leadership roles in several key businesses within the company, including Medicaid and Medicare, clinical program management, account management, health plans, and pharma strategies and contracting. His pioneering approach to pharmaceutical manufacturer relationships and negotiation led to novel solutions that lower costs while improving pharmacy care. A pharmacist by training, he was previously a regional director at Diagnostic, and a staff pharmacist in the University of North Carolina hospital system.
Neville holds a Bachelor of Science degree in Pharmacy from the University of North Carolina and a Master of Business Administration degree from the University of Missouri – St. Louis.
What is Everett Neville's net worth?
The estimated net worth of Everett Neville is at least $1.74 million as of July 19th, 2023. Mr. Neville owns 4,937 shares of The Cigna Group stock worth more than $1,737,676 as of April 18th. This net worth evaluation does not reflect any other assets that Mr. Neville may own. Learn More about Everett Neville's net worth.
How do I contact Everett Neville?
Has Everett Neville been buying or selling shares of The Cigna Group?
Everett Neville has not been actively trading shares of The Cigna Group within the last three months. Most recently, Everett Neville sold 13,157 shares of the business's stock in a transaction on Wednesday, July 19th. The shares were sold at an average price of $295.21, for a transaction totalling $3,884,077.97. Following the completion of the sale, the executive vice president now directly owns 4,937 shares of the company's stock, valued at $1,457,451.77. Learn More on Everett Neville's trading history.
Who are The Cigna Group's active insiders?
The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (CEO), Brian Evanko (Exec. VP & CFO ), Brian Evanko (CFO), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (Insider), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.
Are insiders buying or selling shares of The Cigna Group?
During the last year, insiders at the health services provider sold shares 18 times. They sold a total of 154,668 shares worth more than $50,986,538.23. The most recent insider tranaction occured on March, 25th when CEO David Cordani sold 31,209 shares worth more than $11,084,500.53. Insiders at The Cigna Group own 0.6% of the company.
Learn More about insider trades at The Cigna Group. Information on this page was last updated on 3/25/2024.
